Cosmecca Korea Co. Ltd (241710) - Total Liabilities
Based on the latest financial reports, Cosmecca Korea Co. Ltd (241710) has total liabilities worth ₩365.11 Billion KRW (≈ $247.43 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cosmecca Korea Co. Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Cosmecca Korea Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 241710 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Cosmecca Korea Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Cosmecca Korea Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anhui Jinchun Nonwoven Co Ltd
SHE:300877
|
China | CN¥274.86 Million |
|
Antofagasta PLC
LSE:ANTO
|
UK | GBX10.51 Billion |
|
Riskified Ltd
NYSE:RSKD
|
USA | $102.65 Million |
|
Capital A Berhad
KLSE:5099
|
Malaysia | RM6.46 Billion |
|
Hangzhou Guotai Environmental Protection Technology Co. Ltd. A
SHE:301203
|
China | CN¥56.91 Million |
|
Jiangsu Luokai Mechanical & Electrical Co Ltd Class A
SHG:603829
|
China | CN¥1.42 Billion |
|
Electra Co Pr
TA:ECP
|
Israel | ILA6.72 Billion |
|
One Liberty Properties Inc
NYSE:OLP
|
USA | $557.77 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Cosmecca Korea Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Cosmecca Korea Co. Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cosmecca Korea Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cosmecca Korea Co. Ltd (2016–2025)
The table below shows the annual total liabilities of Cosmecca Korea Co. Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩295.59 Billion ≈ $200.32 Million |
+40.55% |
| 2024-12-31 | ₩210.31 Billion ≈ $142.52 Million |
+10.42% |
| 2023-12-31 | ₩190.46 Billion ≈ $129.07 Million |
-22.61% |
| 2022-12-31 | ₩246.10 Billion ≈ $166.78 Million |
-1.29% |
| 2021-12-31 | ₩249.32 Billion ≈ $168.96 Million |
+8.78% |
| 2020-12-31 | ₩229.20 Billion ≈ $155.33 Million |
+2.69% |
| 2019-12-31 | ₩223.19 Billion ≈ $151.26 Million |
+17.43% |
| 2018-12-31 | ₩190.06 Billion ≈ $128.80 Million |
+405.60% |
| 2017-12-31 | ₩37.59 Billion ≈ $25.47 Million |
-1.61% |
| 2016-12-31 | ₩38.21 Billion ≈ $25.89 Million |
-- |
About Cosmecca Korea Co. Ltd
Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally. It offers skincare products, including lotion/toner, cream, essence, cleansers, Korean herbal products, mask sheet, scalp care, home scents, body and bath, exfoliators, and treatment products, as well as products for men, babies, and children; functional… Read more